Teva Pharmaceuticals (NYSE:TEVA) shares stood firm before hours today on first-quarter earnings that topped the consensus forecast. The Tel Aviv, Israel-based company posted profits of $84 million, or 7¢ per share, on sales of $4 billion for the three months ended March 31, 2021, for a more-than tripled bottom-line despite a sales decline of -8.6%. Get […]
Respiratory
Valeo Pharma closes upsized $6.6M private placement
Valeo Pharma announced today that it closed an upsized private placement worth more than $6.6 million. Montreal, Canada-based Valeo issued 6,645 unsecured, non-convertible debenture units at a purchase price of $1,000 per unit, totaling gross proceeds of $6.645 million, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
Feds to healthcare: Limit reusing masks
The FDA recently told healthcare facilities they can start to limit the decontamination and reuse of disposable masks. An increase in the domestic supply of new masks approved by NIOSH has made the practice less necessary, the agency said. Get the full story on our sister site, Medical Design & Outsourcing.
Getinge wins 3 FDA clearances for ventilators
Getinge announced today that it received FDA 510(k) clearance for three products to expand its Servo platform of ventilators. Gothenburg, Sweden-based Getinge’s latest clearances are for new software options for the Servo-u and Servo-n ventilators, as well as clearance for use of the new Servo-u MR ventilator in the MRI room, according to a news release. […]
LivaNova gains FDA clearance for heart-lung machine
LivaNova (NSDQ:LIVN) announced today that it received FDA 510(k) clearance for its B-Capta system integrated into the S5 heart-lung machine. London-based LivaNova’s B-Capta, a new, in-line, blood-gas monitoring system is to be integrated into the S5 HLM to easily and accurately monitor arterial and venous blood gas parameters even during long and complex pediatric and […]
Medtronic blood pump recall is serious
Medtronic (NYSE: MDT) is recalling a blood pump that can stop during cardiopulmonary bypass surgery due to electrical failure. The Bio-Console 560 extracorporeal blood pumping console is used to pump and return blood to a person during bypass, a procedure that temporarily takes over the function of the heart and lungs. The cardiopulmonary bypass procedure […]
FDA tells hospitals: Stop reusing disposable masks
The FDA issued guidance today recommending that healthcare personnel and facilities cease the reuse of disposable masks. According to the recommendations, healthcare personnel and facilities should transition away from crisis capacity strategies like decontaminating or bioburden reducing disposable respirators for reuse. The CDC’s National Institute for Occupational Safety & Health (NIOSH) approved an increased domestic […]
Dräger acquires majority share of Stimit and its tech to help people breathe
Dräger recently announced that it has acquired a majority stake in Swiss medtech startup Stimit and its noninvasive tech to stimulate intensive care patients’ respiratory muscles. The financial terms of the deal were not disclosed in the April 1 announcement. Stimit will work with Dräger in the following months to further develop the product and […]
Sandia Labs seeks partners to make reusable masks
Sandia National Laboratories has come up with its own version of a reusable respirator for frontline workers. Sandia has filed for patent protection, is testing prototypes, and seeking NIOSH approval and potential manufacturing partners for its elastomeric half-mask N95 respirator. It’s the latest entry to a small but growing category of reusable masks designed to filter at […]
Teva Pharmaceuticals receives European approval for Spiromax inhalers
Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair Spiromax inhalers. Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ fluticasone propionate, 12.75/100 and 12.75/202 micrograms delivered doses) received approval as a maintenance treatment for asthma in adults and adolescents aged 12 years and older, according to a news release. […]
Inogen names former BD exec as chief commercial officer
Inogen (NSDQ:INGN) announced today that its board of directors appointed George Parr as its EVP and chief commercial officer. Goleta, Calif.–based Inogen’s EVP of marketing, Byron Myers, and EVP of sales, Arron Retterer, announced earlier this month that they plan to leave the portable oxygen therapy company, effective June 4, 2021, following a transition period. […]
